Premium
Interleukin‐4 up‐regulation of epidermal interleukin‐19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites
Author(s) -
Bao Lei,
Alexander Jaime B.,
Shi Vivian Y.,
Mohan Girish C.,
Chan Lawrence S.
Publication year - 2014
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/imm.12339
Subject(s) - stat6 , stat protein , janus kinase , biology , stat , interleukin 4 , cytokine , signal transduction , microbiology and biotechnology , interleukin 20 , interleukin , chromatin immunoprecipitation , interleukin 13 , transcription factor , interleukin 5 , gene expression , immunology , stat3 , promoter , gene , genetics
Summary Interleukin‐19 ( IL ‐19) plays an important role in asthma by stimulating T helper type 2 (Th2) cytokine production. Interestingly, IL ‐4, a key Th2 cytokine, in turn up‐regulates IL ‐19 expression in bronchial epithelial cells, so forming a positive feedback loop. In atopic dermatitis ( AD ), another Th2 disease closely related to asthma, IL ‐19 is up‐regulated in the skin. We propose to use IL ‐4 transgenic (Tg) mice and human keratinocyte culture to delineate the molecular mechanisms involved in the up‐regulation of IL ‐19 in AD . IL ‐19 is similarly up‐regulated in the skin of IL ‐4 Tg mice as in human AD . Next we show that IL ‐4 up‐regulates IL ‐19 expression in keratinocytes. Interestingly, the up‐regulation was suppressed by a pan‐Janus kinase (Jak) inhibitor, suggesting that the Jak–signal transducer and activator of transcription (Jak‐STAT) pathway may be involved. Dominant negative studies further indicate that STAT6, but not other STATs, mediates the up‐regulation. Serial 5′ deletion of the IL ‐19 promoter and mutagenesis studies demonstrate that IL ‐4 up‐regulation of IL ‐19 in keratinocytes involves two imperfect STAT6 response elements. Finally, chromatin immunoprecipitation assay studies indicate that IL ‐4 increases the binding of STAT6 to its response elements in the IL ‐19 promoter. Taken together, we delineate the detailed molecular pathway for IL ‐4 up‐regulation of IL ‐19 in keratinocytes, which may play an important role in AD pathogenesis.